Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of "More Stamina," a gamified mobile health (mHealth) app designed to help people with multiple sclerosis ...